Maxi Wass

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

Christoph Röllig, Michael Krämer, Christoph Schliemann et al. · Blood · 2020 · 133 citations · Full text

A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy

Maxi Wass, Stefanie Göllner, Birgit Besenbeck et al. · Leukemia · 2020 · 95 citations · Full text

Intensive Therapy, Psychoactive Drug, Medicine +6

Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia

Christina Rautenberg, Friedrich Stölzel, Christoph Röllig et al. · Blood Cancer Journal · 2021 · 62 citations · Full text

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

Matthias Stelljes, Jan Moritz Middeke, Gesine Bug et al. · The Lancet Haematology · 2024 · 44 citations · Full text

Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19

Christoph Schultheiß, Lisa Paschold, Edith Willscher et al. · iScience · 2021 · 41 citations · Full text